The present invention relates to an antibody for detecting acetylation of cyclooxygenase 2 (COX2) protein and to a use thereof and, more specifically, to an antibody specifically recognizing the acetylation of S565 residue of the COX2 protein and to a use for diagnosing degenerative neurological disease or inflammatory disease. Since the antibody or a functional fragment thereof of the present invention specifically binds to the residue of the acetylated COX2 protein, it is very usefully utilized in the diagnosis of degenerative neurological disease, inflammatory disease, and the like in which the degree of the acetylation of the S565 residue of the COX 2 protein is reduced.
COX2 Antibody for detecting acetylation of cyclooxygenase 2 and uses thereof